Know Cancer

or
forgot password

Diagnosis of Sceletal Metastases in c. Mammae: 18F-NaF-PET/Lowdose-CT Versus 99mTc HDP Bone Scintigraphy


N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Diagnosis of Sceletal Metastases in c. Mammae: 18F-NaF-PET/Lowdose-CT Versus 99mTc HDP Bone Scintigraphy


Inclusion Criteria:



- histologically proven c. mammae

- clinically suspicion of bone metastases

Exclusion Criteria:

- age under 18 years

- diabetes mellitus

- pregnancy

- other known malignant disease

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Christine Winkler, Dr.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dep. of Nuclear Medicine & PET, Rigshospitalet, Denmark

Authority:

Denmark: The Danish National Committee on Biomedical Research Ethics

Study ID:

H-3-2010-019

NCT ID:

NCT01224873

Start Date:

October 2010

Completion Date:

September 2013

Related Keywords:

  • Breast Cancer
  • breast cancer
  • bone metastasis
  • comparison of diagnostic methods
  • bone scintigraphy
  • fluoride PET/CT
  • FDG-PET/CT
  • Breast Neoplasms
  • Neoplasm Metastasis

Name

Location